NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$28.10
-2.23%
Mkt Cap $3.42B
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
Implied Upside
+63.7%
Consensus $46.00 vs current $28.10
NASDAQ·Healthcare·Biotechnology
$28.10
-2.23%
Mkt Cap $3.42B
Buy
6
Hold
1
Sell
0
Price Target (11 analysts)
$46.00
Range $37.00 – $55.00
+63.7%
Consensus $46.00 vs current $28.10